Evidence map›Paper›PMID 42866488›Full record

ReviewJSES reviews, reports, and techniques2026

Evaluation and management of neuropathic arthropathy of the shoulder: narrative review.

Tarek Haj Shehadeh, Ryan Lohre, Bassem Elhassan

Abstract readReview
In one paragraph

Review in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tarek Haj ShehadehLevitetz Department of Orthopedic Surgery, Cleveland Clinic Florida, Weston, FL, USA.
Ryan LohreDepartment of Orthopedic Surgery, Mass General Hospital, Harvard Medical School, Boston, MA, USA.
Bassem ElhassanDepartment of Orthopedic Surgery, Mass General Hospital, Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic arthropathy of the shoulder, or Charcot shoulder, is a rare and destructive neuroarthropathy resulting from impaired protective sensation and altered joint mechanics that is most commonly associated with syringomyelia. The pathogenesis is believed to involve both neurotraumatic and neurovascular mechanisms, resulting in progressive osseous destruction, joint instability, and soft tissue compromise. Clinical presentation varies, with painless swelling, joint effusion, crepitus, and progressive limitation in shoulder function commonly reported. Radiographic findings frequently demonstrate rapid joint destruction, humeral head collapse, fragmentation, and periarticular bone resorption. Accurate diagnosis requires a thorough clinical assessment combined with imaging and laboratory evaluation to exclude other causes of joint destruction. Advanced imaging is important in identifying associated neurologic abnormalities and early joint changes. Management strategies remain challenging and must be individualized based on symptom severity, functional demands, and the underlying neurologic condition. Non-operative treatment remains the first-line approach for many patients, particularly in early or less symptomatic stages. Surgical management may be considered in cases with severe pain, instability, or significant functional impairment. Although arthrodesis was historically the primary surgical option, advancements in shoulder arthroplasty and tendon transfer techniques have expanded treatment strategies.

Indexed as

Charcot neuroarthropathyCharcot shoulderCharcot shoulder evaluationCharcot shoulder managementNeuropathic arthropathyShoulder neuroarthropathy

Identifiers

PMID42866488
PMCPMC13656534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.